Episode 24: Gadi Lachman, President and CEO, TriNetX

Episode 24 October 06, 2022 00:39:58
Episode 24: Gadi Lachman, President and CEO, TriNetX
Few & Far Between: Conversations from the Front Lines of Drug Development
Episode 24: Gadi Lachman, President and CEO, TriNetX

Oct 06 2022 | 00:39:58

/

Show Notes

Can data sharing make the world a better place? Listen in to the latest episode of Few & Far Between. Biorasi CEO, Chris O'Brien, welcomes Gadi Lachman, President and CEO of TriNetX, to discuss real-world solutions for accessing and refining patient data in the clinical trials industry.

Other Episodes

Episode 37

January 24, 2024 00:41:31
Episode Cover

Episode 37: Will Greene, Prader-Willi Syndrome patient advocate, Healthcare Engagement Lead at Roche

"The history of rare disease drug development indicates that once you start looking harder for cases, you often tend to find them." - Will...

Listen

Episode 1

May 18, 2021 00:41:00
Episode Cover

Episode 1: Paula Evans, CEO and Co-Founder of GeneTx Biotherapeutics

On today’s podcast, Jimmy El Hokayem, Head of the Neurology and Regenerative Medicine Centers of Excellence and Associate Director of Program Development at Biorasi,...

Listen

Episode 35

November 14, 2023 00:44:55
Episode Cover

Episode 35: Charlene Son Rigby, CEO at Global Genes

"And what I was really surprised about was that everybody was doing data collection in a different way. And I kept thinking that, gosh,...

Listen